Important Benefits of EBUS-TBNA in Assessing PD-L1 Expression in NSCLC

被引：0
|
作者：
Centanaro, Gianna Vargas [1 ]
Forcen, Elena [1 ]
Morales, Beatriz [1 ]
Alvarez-Sala, J. L. [1 ]
Calle, Myriam [1 ]
Bernabe, M. Jose [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Lung cancer; Bronchoscopy; Lung cancer - diagnosis;
D O I：
10.1183/13993003.congress-2020.1695
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1695
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Correlation between PD-L1 expression and clinicopathological characterization in NSCLC
    Jin, Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 143 - 143
  • [42] Prevalence of PD-L1 Expression Rates in Different NSCLC Specimens
    Holmes, M.
    Mahar, A.
    Lum, T.
    Boyer, M.
    Kao, S.
    Cooper, W.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S506 - S506
  • [43] Expression status of PD-L1 in NSCLC correlates with disease extension
    Yamamoto, Aya
    Iwata, Takashi
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [44] PD-L1 expression in NSCLC and the comparison with the other types of cancer
    Acar, E.
    Akyurek, N.
    VIRCHOWS ARCHIV, 2018, 473 : S311 - S311
  • [45] YAP regulates PD-L1 expression in human NSCLC cells
    Miao, Jinbai
    Hsu, Ping-Chih
    Yang, Yi-Lin
    Xu, Zhidong
    Dai, Yuyuan
    Wang, Yucheng
    Chan, Geraldine
    Huang, Zhen
    Hu, Bin
    Li, Hui
    Jablons, David M.
    You, Liang
    ONCOTARGET, 2017, 8 (70) : 114576 - 114587
  • [46] Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
    Janning, Melanie
    Kobus, Franca
    Babayan, Anna
    Wikman, Harriet
    Velthaus, Janna-Lisa
    Bergmann, Sonja
    Schatz, Stefanie
    Falk, Markus
    Berger, Lars-Arne
    Boettcher, Lisa-Marie
    Paesler, Sarina
    Gorges, Tobias M.
    O'Flaherty, Linda
    Hille, Claudia
    Joosse, Simon A.
    Simon, Ronald
    Tiemann, Markus
    Bokemeyer, Carsten
    Reck, Martin
    Riethdorf, Sabine
    Pantel, Klaus
    Loges, Sonja
    CANCERS, 2019, 11 (06):
  • [47] EBUS-TBNA in Metastatic NSCLC: Do Cytomorphological Features Correlate with Standardized Uptake Value of PET Scan?
    Keyhanian, Kianoosh
    Sekhon, Harman S.
    MODERN PATHOLOGY, 2017, 30 : 101A - 101A
  • [48] Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience
    Karadzovska-Kotevska, Marija
    Brunnstrom, Hans
    Kosieradzki, Jaroslaw
    Ek, Lars
    Estberg, Christel
    Staaf, Johan
    Barath, Stefan
    Planck, Maria
    PLOS ONE, 2022, 17 (02):
  • [49] Correlation Between PD-L1 Gene Promoter Polymorphisms and Expression of PD-L1 mRNA and Protein in NSCLC Patients.
    Kucharczyk, T.
    Grenda, A.
    Krawczyk, P.
    Nicos, M.
    Jarosz, B.
    Szumilo, J.
    Reszka, K.
    Trojanowski, T.
    Milanowski, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S732 - S732
  • [50] Extrinsic Upregulation of PD-L1 Induced by Pembrolizumab Combination Therapy in Patients with NSCLC with Low Tumor PD-L1 Expression
    Kunimasa, Kei
    Nakamura, Harumi
    Nishino, Kazumi
    Nakatsuka, Shin-ichi
    Kumagai, Toru
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : E231 - E233
12345